Sempra
NYSE:SREDiversified Utilities
-$0.05 today
- Market cap
- $50.69B
- Beta
- 0.58
- P/E (TTM)
- 28.5
- EPS (TTM)
- $3.17
- Dividend yield
- 2.87%
Volume 3.38M
Average 3.74M
SRE Common Stock Issued
Cash raised by issuing new shares.
SempraNYSE: SRE
Common Stock Issued · Q2 FY2026 · quarter ended Jun 2026
Common stock issued growth accelerates
Q2 FY2026 common stock issued of $21M rose 133.3% year over year, ahead of the -96.5% change in trailing-twelve-month common stock issued. Sequentially, it rose 133.3% from the prior quarter. Over 3 fiscal years it compounded at +100.0% a year.
Context
- Common stock issued amounted to 0.2% of revenue in FY2025, down 9.2 pp from a year earlier.
- Common stock issued increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +133.3% holds above the trailing-twelve-month pace of -96.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 32M USD
- Year-over-year change
- -97.4%
- 4-year CAGR
- +59.1%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 32M | -97.4% |
| FY2024 | 2024-12-31 | 1.22B | +740.7% |
| FY2023 | 2023-12-31 | 145M | +3525.0% |
| FY2022 | 2022-12-31 | 4M | -20.0% |
| FY2021 | 2021-12-31 | 5M | — |
Common Stock Issued vs competitors
How SRE compares with its peers on the latest reported figures
- SRE's LTM Jun 2026 common stock issued of $43M is the 7th largest of the 11 companies compared; the peer median is $287.7M.
- Its year-over-year change of -96.5% is the 8th highest of 9, against a peer median of +31.7%.
- Common stock issued amounts to 0.3% of revenue for SRE, versus a peer median of 2.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.67B | +1280.2% | +2.4% | 5.5% | |
| LTM Jun 2026 | $1.08B | +85.0% | -73.0% | 21.9% | |
| LTM Jun 2026 | $1.04B | +4216.7% | +96.7% | 11.8% | |
| LTM Sep 2026 | $597M | +545.5% | — | 6.5% | |
| LTM Jun 2026 | $410.4M | -21.7% | — | 4.0% | |
| LTM Jun 2026 | $165M | -33.2% | — | 1.7% | |
| LTM Jun 2026 | $43M | -96.5% | +100.0% | 0.3% | |
| LTM Jun 2026 | $23M | -73.0% | -17.1% | 1.2% | |
| LTM Sep 2026 | $0 | -100.0% | +21.1% | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SRE) | $287.7M | +31.7% | +2.4% | 2.9% | |
Competitors are the stored peer set for SRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.46B | 2.29B | 3.62B | 3.5B | 866M |
| Depreciation & Amortization | 1.86B | 2.02B | 2.23B | 2.44B | 2.56B |
| Deferred Income Tax | (78M) | 392M | 249M | (20M) | 533M |
| Stock-Based Compensation | 63M | 71M | 80M | 86M | 0 |
| Change in Working Capital | 583M | (4.02B) | 835M | (612M) | 145M |
| Accounts Receivables | (599M) | (976M) | 168M | 118M | (66M) |
| Inventory | (87M) | (17M) | (80M) | (74M) | (64M) |
| Accounts Payables | 263M | 430M | (270M) | (131M) | (7M) |
| Other Working Capital | 1.01B | (3.46B) | 1.02B | (525M) | 282M |
| Other Non-Cash Items | (44M) | 397M | (791M) | (484M) | 458M |
| Operating Cash Flow | 3.84B | 1.14B | 6.22B | 4.91B | 4.57B |
| Capital Expenditures | (5.02B) | (5.36B) | (8.4B) | (8.22B) | (10.61B) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 327M |
| Purchases of Investments | (1.59B) | (1.08B) | (992M) | (1.88B) | (3.05B) |
| Sales of Investments | 999M | 762M | 661M | 942M | 1.1B |
| Other Investing Activities | 102M | 632M | 12M | 32M | 23M |
| Investing Cash Flow | (5.51B) | (5.04B) | (8.72B) | (9.12B) | (12.21B) |
| Debt Repayment | 197M | 4.21B | 1.93B | 4.78B | 7.32B |
| Common Stock Issued | 5M | 4M | 145M | 1.22B | 32M |
| Common Stock Repurchased | (339M) | (478M) | (32M) | (43M) | (958M) |
| Dividends Paid | (1.43B) | (1.47B) | (1.53B) | (1.54B) | (1.64B) |
| Other Financing Activities | 2.83B | 1.52B | 2.05B | 1.01B | 4.85B |
| Financing Cash Flow | 1.26B | 3.78B | 2.42B | 5.42B | 9.6B |
| Effect of Forex Changes | 2M | (1M) | 6M | (13M) | (3.51B) |
| Net Change in Cash | (404M) | (119M) | (73M) | 1.2B | (1.56B) |
| Free Cash Flow | (1.17B) | (4.22B) | (2.18B) | (3.31B) | (6.05B) |
Sempra
NYSE:SRE
Intrinsic Alpha fair value
Locked
Current Price
$77.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.